Dr. Jack West, Swedish Cancer Institute, discusses the anti-angiogenic agent bevacizumab (Avastin) and the trial evidence of its efficacy for non-squamous NSCLC.
Dr. Jack West, Swedish Cancer Institute, identifies the platinum-based chemotherapy doublet as the backbone of first-line treatment for the majority of NSCLC patients.
Dr. Ross Camidge, University of Colorado, addresses the question of whether to use a second generation ALK inhibitor as first line therapy or only after acquired resistance to crizotinib.
Dr. Ross Camidge, University of Colorado, discusses management of CNS progression for ALK-positive NSCLC including monitoring frequency and preferences between systemic and radiation therapy.
Dr. Ross Camidge, University of Colorado, describes the second generation ALK-inhibitors which provide good options for ALK-positive NSCLC patients who have developed acquired resistance to crizotinib.
Drs. Mary Pinder, Nate Pennell, and Jack West discuss the results presented at ASCO 2013 of the GALAXY-1 trial of the HSP90 inhibitor ganetespib...
Dr. Karen Kelly, of the University of California, Davis, gives her view on more widespread availability of new mutation tests. [powerpress]
Drs. Nate Pennell, Mary Pinder, and Jack West review the results presented at ASCO 2013 from the POINTBREAK trial of maintenance therapy with the ECOG...
Drs. Nate Pennell, Mary Pinder, and Jack West review the results presented at ASCO 2013 from the PRONOUNCE trial of the ECOG 4599 trial regimen...
Dr. Phil Bonomi, from Rush University, describes which patients with advanced non-small cell lung cancer he would recommend getting a repeat biopsy to...
Hello everyone, my father was diagnosed with stage 4 NSCLC with mets to his bones and brain. He was on Tarceva for about 3 months (he felt better...
March 18, 2018 at 1:24 am #1294108 song1234 Hello everyone, my father was diagnosed with stage 4 NSCLC with mets to his bones and brain. He was on...
I have stage 4 NSCLC adenocarcinoma with bone metastasis. I started carboplatin Alimta Avastin chemo treatment and wondering if this triplet is...
The lymphocyte gate consists of small, hypogranular, CD45 positive cells, which comprise 4% of the total events. The majority are T-lymphocytes (CD3...
Swansea University is conducting research into people’s views and experiences of undergoing different types of bladder reconstruction - ClinicalTrials...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.